GLYCOMIMETICS INC's ticker is GLYC and the CUSIP is 38000Q102. A total of 81 filers reported holding GLYCOMIMETICS INC in Q4 2017. The put-call ratio across all filers is 2.13 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2020 | $138,000 | -62.3% | 60,331 | -12.7% | 0.06% | -5.0% |
| Q4 2019 | $366,000 | +277.3% | 69,120 | +206.1% | 0.06% | +200.0% |
| Q3 2019 | $97,000 | -65.8% | 22,580 | -5.3% | 0.02% | -66.7% |
| Q2 2019 | $284,000 | -14.2% | 23,838 | -10.2% | 0.06% | -91.5% |
| Q1 2019 | $331,000 | +17.0% | 26,550 | -11.1% | 0.70% | +1366.7% |
| Q4 2018 | $283,000 | -31.8% | 29,862 | +3.7% | 0.05% | +11.6% |
| Q3 2018 | $415,000 | -47.9% | 28,805 | -41.7% | 0.04% | -93.9% |
| Q2 2018 | $797,000 | +5.6% | 49,395 | +6.2% | 0.70% | +7.6% |
| Q1 2018 | $755,000 | +114.5% | 46,525 | +122.0% | 0.66% | +48.2% |
| Q4 2017 | $352,000 | -13.1% | 20,957 | -27.6% | 0.44% | +703.6% |
| Q3 2017 | $405,000 | +37.8% | 28,961 | +10.1% | 0.06% | +25.0% |
| Q2 2017 | $294,000 | – | 26,312 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BVF INC/IL | 3,229,856 | $45,186,000 | 5.74% |
| NEA Management Company, LLC | 8,584,128 | $120,092,000 | 4.21% |
| NEXTHERA CAPITAL LP | 321,286 | $4,495,000 | 1.16% |
| Redmile Group, LLC | 1,214,088 | $16,985,000 | 0.84% |
| EAM Investors, LLC | 371,030 | $5,191,000 | 0.69% |
| Schonfeld Strategic Advisors LLC | 500,104 | $6,996,000 | 0.64% |
| ELEMENT CAPITAL MANAGEMENT LLC | 29,909 | $418,000 | 0.17% |
| Jafra Capital Management LP | 16,839 | $236,000 | 0.09% |
| PRENTISS SMITH & CO INC | 20,000 | $280,000 | 0.08% |
| Endurant Capital Management LP | 17,607 | $246,000 | 0.08% |